Mammography Systems Financing

Mammography equipment earns revenue one exam at a time, and a room that runs 25 to 35 studies per day on a reliable 2D or 3D system is one of the more predictable revenue generators in a diagnostic imaging center. The equipment driving that volume, whether a full-field digital mammography (FFDM) system or a 3D tomosynthesis unit, runs from approximately $90,000 for a refurbished 2D system to $300,000 or more for a new 3D tomosynthesis configuration with a biopsy option. That range makes financing the standard approach for most independent women's health programs and hospital radiology departments adding or replacing mammography capacity.

We finance mammography systems, new and used, for outpatient imaging centers, women's health practices, hospital radiology departments, and mobile mammography programs. Deals start at $50,000. Application-only approvals are available up to approximately $400,000, and funding typically closes in one to two weeks. B/C credit is considered.

Mammography System Configurations and Price Points

Full-field digital mammography (FFDM) systems replaced film-screen and computed radiography mammography as the standard of care over the past two decades. Current FFDM systems from manufacturers like Hologic, GE, Siemens, Fujifilm, and Canon produce high-resolution 2D images at doses well below film-screen levels. The GE Senographe Pristina and comparable current-generation FFDM systems represent the entry point for new 2D mammography investment.

Three-dimensional tomosynthesis systems, which acquire a series of low-dose images through the breast at multiple angles and reconstruct them into thin slice images, add meaningful clinical capability over standard 2D. Tomosynthesis reduces callback rates and improves cancer detection in dense breast tissue compared to 2D alone, which has clinical, patient satisfaction, and downstream revenue implications. Adding tomosynthesis capability to a 2D system through a software and hardware upgrade or purchasing a new combined 2D/3D system both qualify for financing.

Stereotactic biopsy systems add vacuum-assisted core biopsy capability to a mammography platform, converting a diagnostic imaging unit into an interventional system as well. Programs that want to bring biopsy in-house rather than referring to a separate facility can finance both the mammography platform and the stereotactic biopsy attachment in a single transaction. We also finance dedicated stereotactic breast biopsy systems separately for programs that already have a mammography unit and are adding biopsy capability.

Who Finances Mammography Equipment

The buyer spectrum for mammography financing ranges from large radiology practices replacing aging units to independent women's health centers opening their first dedicated mammography room. Women's health and OB/GYN clinics that add on-site mammography avoid sending patients to a separate imaging center for their annual screening, which reduces patient inconvenience and captures the professional and technical component revenue in the practice. For a busy OB/GYN practice with a large panel of women over 40, the volume to justify a dedicated mammography unit can materialize faster than most practices expect.

Hospital radiology departments replace mammography systems on a cycle driven by equipment age, vendor support availability, and the clinical gap between their current system's capability and current standards. The addition of tomosynthesis capability is the most common driver of mid-cycle replacement, as practices feel pressure to match the screening performance that patients and referring physicians expect from a modern mammography program.

Mobile mammography programs, which mount digital mammography systems in coaches or trailers to serve underserved communities, employer groups, and rural populations, represent a specialized buyer segment. The financing of the mammography system itself and the vehicle or trailer it mounts in can sometimes be combined into a single transaction, or the imaging equipment can be financed separately from the mobile vehicle platform.

Financing New versus Refurbished Mammography Systems

Used and refurbished mammography systems, particularly 2D FFDM units from the 2012 to 2020 period, are widely available through biomedical equipment vendors. A refurbished Hologic Selenia Dimensions or comparable 2D unit in sound condition can provide years of additional service at 40 to 60 percent of new-equipment cost. These units are appropriate for programs that need reliable 2D screening capacity without the tomosynthesis premium, or for secondary screening locations that complement a flagship 3D program.

Refurbished units with tomosynthesis capability are also available but require careful evaluation of the detector condition and software version. Tomosynthesis software is proprietary, and older software versions may not support current acquisition protocols or reporting integrations. Verifying software current-version status before committing to a refurbished tomosynthesis system is a worthwhile step, and a reputable biomedical vendor will be able to confirm this before sale. Used equipment financing is available for refurbished mammography systems with appropriate documentation, and terms adjust based on equipment age and condition.

Payment Structures for Mammography Systems

Loan terms for mammography systems most commonly run 60 to 72 months, with 84-month terms available for newer systems with longer useful lives. The monthly payment on a $200,000 new tomosynthesis system financed over 60 months lands in a range that a program doing 15 or more studies per day typically covers within the first week or two of monthly billing. Running the reimbursement math on your exam volume against the projected payment is the most direct way to assess whether the financing is conservative, comfortable, or tight. X-ray equipment loans and leases are both available for mammography; a loan suits programs that want straightforward ownership while a lease suits programs anticipating an upgrade cycle.

Lease structures, including fair market value leases, suit programs that expect to upgrade to future tomosynthesis or AI-assisted reading platforms at the end of the initial term. A five-year FMV lease preserves that upgrade optionality without committing to ownership of technology that may be meaningfully outperformed by a new generation of equipment in five to seven years. Dollar-buyout leases are more appropriate for programs that want long-term ownership at a predictable total cost.

Related Financing Paths